Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality (Q39793210)

14 September 2017

title

Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality (English)

1 reference

14 September 2017

Gulcin Benbir

1

1 reference

14 September 2017

Birsen Ince

2

1 reference

14 September 2017

Emre Kumral

3

1 reference

14 September 2017

Zeki Ongen

4

1 reference

14 September 2017

Hakan Kultursay

5

1 reference

14 September 2017

Lale Tokgozoglu

6

1 reference

14 September 2017

Ali Oto

7

1 reference

14 September 2017

Hasan Tuzun

8

1 reference

14 September 2017

ARDA Investigators

9

1 reference

14 September 2017

publication date

1 February 2012

1 reference

14 September 2017

1 reference

14 September 2017

volume

35

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

65-73

1 reference

https://scigraph.springernature.com/pub.10.1007/s10753-010-9290-4

14 September 2017

exact match

0 references

cites work

Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

The Barthel ADL Index: a standard measure of physical disability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

High sensitivity C-reactive protein as an independent risk factor for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Is C-reactive protein an independent risk factor for essential hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Hypertension and stroke--rationale behind the ACCESS trial. Acute Candesartan Cilexetil Evaluation in Stroke Survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Angiotensin receptor blockers and cerebral protection in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Antithrombotic and antihypertensive management 3 months after ischemic stroke : a prospective study in an inner city population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

C-reactive protein and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Association between blood pressure and C-reactive protein levels in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9290-4

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy

21 January 2018

1 reference

12 December 2020

Blood pressure control in Italy: results of recent surveys on hypertension

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

Is the level of C-reactive protein correlated with the extent of carotid atherosclerosis?

1 reference

12 December 2020

Recovery of motor function after stroke

1 reference

12 December 2020

Post-stroke antihypertensive treatment study. A preliminary result

1 reference

12 December 2020

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

12 December 2020

10.1007/S10753-010-9290-4

Identifiers

DOI

1 reference

14 September 2017

1 reference